Abstract
The presence of Babesia spp. was studied in 2603 Ixodes ricinus and Ixodes persulcatus ticks collected at seven sites in Estonia. By reverse line blot screening, Babesia spp. was detected in 36 (1.4%) ticks, among them 18 (0.7%) were further recognized by a Babesia microti probe, 3 (0.1%) by a Babesia divergens probe, and the other 15 (0.6%) were recognized only by the universal Babesia spp. “catch all” probe. Sequence analyses of 6 of these 15 samples revealed that all of them belonged to Babesia sp. EU1. B. microti was detected in both tick species I. ricinus and I. persulcatus at the seven sites, whereas B. divergens-like and Babesia sp. EU1 were found only in I. persulcatus and I. ricinus, respectively. Genetic characterization based on partial 18S rRNA showed that the Estonian sequences of B. microti, B. divergens-like, and Babesia sp. EU1 share a high rate of similarity and are closely related to sequences from other European countries, Siberia, and United States. The present study demonstrated for the first time the existence and distribution of Babesia spp. in I. persulcatus and I. ricinus ticks in Estonia.
Introduction
Ticks from the genus Ixodes spp. are the main vectors involved in Babesia transmission. In Estonia, two tick species, I. ricinus and I. persulcatus, are prevalent and widely distributed, whereas in other European countries, I. ricinus is the most representative tick and plays a central role in the transmission of Babesia spp. The distribution of I. persulcatus is restricted to southeastern Estonia, whereas I. ricinus circulates in the whole territory of Estonia (Golovljova et al. 2004).
No studies concerning Babesia have been performed in Estonia. The present study was undertaken to investigate the prevalence of Babesia in ticks collected from different parts of Estonia and to characterize the pathogen by molecular methods.
Materials and Methods
Collection of ticks
Tick sampling was performed from April to November 2006–2008 at different sites in Estonia (Andineeme, Oonurme, Laeva, Järvselja, Kilingi-Nõmme, Are, Puhtu) (Fig. 1). Ticks were collected from the vegetation by flagging and pooled into groups of five adults or nymphs according to tick species, sampling date, and place of collection. Ticks (adults and nymphs) from incomplete pools were processed individually. Pools or individual ticks were washed with sterile phosphate-buffered saline, homogenized in 400 μL of phosphate-buffered saline and stored at −70°C. Two hundred microliters of suspension was used for DNA extraction.

Tick sampling sites in Estonia (Andineeme, Oonurme, Laeva, Järvselja, Kilingi-Nõmme, Are, Puhtu) and the prevalence of Babesia spp. The areas of Ixodes persulcatus and Ixodes ricinus distribution are indicated.
DNA extraction
DNA was extracted with TriPure RNA isolation reagent (Roche Diagnostics) according to the manufacturer's instructions, resuspended in 50 μL of water, and stored at −20°C.
Polymerase chain reaction for the amplification of partial 18S rRNA gene and reverse-line blot hybridization
For screening of ticks, reverse-line blot (RLB) was performed as described earlier (Gubbels et al. 1999). Briefly, the partial 18S rRNA gene of the Babesia spp. was amplified with forward primer RLB-F2 and reverse primer RLB-R2 (Table 1). Polymerase chain reaction (PCR) amplification was carried out in a total reaction volume of 50 μL, which contained the following mix of reagents: GeneAmp 10 × PCR buffer II, MgCl2 (1 mM), dNTPs (200 μM) (Fermentas, EE), 500 nM of forward and reverse primers, AmpliTaq DNA polymerase (1.25 U; Applied Biosystems, Roche), and 10 μL of target DNA. The PCR conditions consisted of a denaturation step of 3 min at 94°C; followed by 10 cycles of touchdown program, consisting of 20 s of denaturation at 94°C, 30 s at annealing temperature decreased from 67°C to 58°C in each cycle, and an extension step of 30 s at 72°C; and then 40 cycles of denaturing step of 20 s at 94°C, an annealing step of 30 s at 57°C, and an extension step of 30 s at 72°C. A final extension step of 10 min at 72°C completed the program.
PCR, polymerase chain; RLB, reverse-line blot.
Preparation of RLB membrane, hybridization, and subsequent stripping of the membrane were carried out as previously described (Gubbels et al. 1999), with the following modifications. The amplification reaction volume (50 μL) was loaded onto the blot after dilution with 2 × SSPE (360mM NaCl, 20 mM Na2HPO4 × H2O, 2 mM EDTA)–0.1% sodium dodecyl sulfate to a total volume of 150 μL. The temperature of the two 10-min posthybridization washes in 2 × SSPE–0.5% sodium dodecyl sulfate was increased to 51°C. After developing, the PCR products were stripped from the membrane.
All the nucleotide sequences of the species-specific oligonucleotide probes containing a N-terminal N-(trifluoracetamidohexyl-cyanoethyle, N,N-diisopropyl phoshoramidite)-C6 amino linker were synthesized by TAGC. The sequences of the oligonucleotide probes are shown in Table 1.
Sequencing of the partial 18S rRNA gene
The samples positive by the RLB assay were amplified by nested PCR for sequencing of the partial 18S rRNA gene with outer primers PIRO-A and RLB-R2 and inner primers RLB-F2 and PIRO-B (Table 1). The PCR amplifications were performed in a total volume of 25 μL as follows: GeneAmp 10 × PCR buffer II, MgCl2 1.5 mM for the first PCR and 0.5 mM for the nested PCR, dNTPs 200 μM for the first PCR and 400 μM for the nested PCR, 1 μM of forward and reverse primers, AmpliTaq DNA polymerase (1.25 U; Applied Biosystems, Roche), and 5 μL of target DNA. The cycling conditions were an initial denaturation for 1 min at 94°C, followed by 40 cycles of 1 min at 94°C, 1 min at 59°C, and 1 min at 72°C. For the nested PCR, the annealing temperature was 55°C.
The amplified products of the nested PCR were purified with GFX-PCR kit (Amersham Biosciences) according to the manufacturer's instructions. The purified PCR products were used as templates in the sequencing reaction using the dideoxynucleotide chain termination method with BigDye Terminator Cycle Sequencing Ready Reagent Kit (ABI PRISM, PE Applied Biosystems). The ABI PRISM 3100 Genetic Analyzer (Applied Biosystems) was used for sequence analysis. The obtained sequences were edited using the BioEdit program (
Phylogenetic analysis
Phylogenetic analysis was carried out with the TREE-PUZZLE 5.2 version package. For phylogenetic tree reconstruction, a quartet puzzling Maximum Likelihood method was used and 10,000 puzzling steps were applied using the Hasegawa-Kishino-Yano model for substitution (Hasegawa et al. 1985). The sequences of the partial 18S rRNA genes for the Babesia species were retrieved from the GenBank database and aligned by BioEdit program (
Nucleotide sequence accession numbers
The sequences of the partial 18S rRNA gene detected in the present study were deposited in the GenBank database under numbers running from HQ629933 to HQ629948.
Results
Detection of Babesia sp. in ticks by RLB hybridization
A total of 2603 ticks including 938 I. persulcatus (577 adults and 361 nymphs) and 1665 I. ricinus (587 adults and 1078 nymphs) were collected from different parts of Estonia in 2006–2008 (Fig. 1).
All ticks were tested for the presence of Babesia spp. by RLB. The presence of Babesia was detected in 36 pools of ticks (1.4%), among them 18 (0.7%) were recognized by the B. microti probe, 3 (0.1%) by B. divergens probe, and the other 15 (0.6%) were recognized only by the universal Babesia spp. “catch all” probe on the membrane (Table 2). B. microti was detected in 4 pools of I. persulcatus (3 pools of females and 1 pool of males) from the eastern part of Estonia (Laeva, Oonurme and Järvselja) and in 14 I. ricinus nymph pools, which were collected in the western part of Estonia (Andineeme, Puhtu, Are, and Kilingi-Nõmme). Three pools—I. persulcatus (two males and one female) from the Järvselja collection site—reacted with the B. divergens probe. Fifteen tick pools (13 pools of I. ricinus nymphs and 2 of I. persulcatus) with undetermined Babesia species by RLB originated from Oonurme, Puhtu, Laeva, Andineeme, Kilingi-Nõmme, and Are. The minimum infection rate was calculated by assuming that only one tick out of five in a pool was positive. The prevalence rates of Babesia species at different geographical sites are shown in Figure 1 and Table 2.
No. of samples confirmed as EU1 by sequencing.
MIR, minimum infection rate.
Sequencing and phylogenetic analysis of partial 18S rRNA gene
For confirmation of the Babesia findings, 16 samples found to be positive by RLB (8 recognized by the B. microti probe, 2 recognized by the B. divergens probe, and 6 recognized by the Babesia spp. “catch all” probe) were amplified and sequenced in the 18S rRNA gene region.
B. microti DNA was amplified from I. persulcatus (Est603, Est884) and I. ricinus (Est 923, Est939, Est941, Est1033, Est1078, Est1098). Seven of eight amplicons were found identical for the 378-bp amplicon of the 18S rRNA gene to sequences previously found in a human blood sample (GenBank EF413181) in Germany and also to sequences from I. ricinus ticks and rodents from Slovenia (GenBank AF373332, AY149572) and Switzerland (GenBank AF494286). However, the sequence of the B. microti sample Est884 differed from the other Estonian sequences by two nucleotide substitutions at positions 614 (A/G) and 699 (T/C), which made it distinct from other published sequences by at least one substitution. On the phylogenetic tree, the Estonian B. microti samples clustered together with strains belonging to the zoonotic “US” type, which is distributed worldwide, and has been reported as pathogenic for humans (Gray et al. 2010) (Fig. 2). The Estonian sequences share a high rate of similarity (99.7%–100%) with other sequences belonging to the “US” type; 98.4% similarity was found with sequences belonging to the Hobetsu and Kobe types, whereas the lowest similarity rate (95.8%–96.3%) was demonstrated with Munich-type strains.

Phylogenetic tree based on partial 18S rRNA gene (378 bp) sequences of Babesia species. The phylogenetic tree was constructed using the quartet puzzling maximum likelihood method (TREE-PUZZLE program). The numbers on the nodes are bootstrap values based on 10,000 replicates (only values >70% are shown). Plasmodium falciparum has been used as the outgroup. The GenBank accession numbers for the sequences used in the present study are given. Est923* is identical to sequences Est939, Est941, Est1033, Est1078, and Est1098; Est788** is identical to sequences Est670, Est916, Est1148, Est1362, and Est1444. The Estonian sequences from this study are in bold.
The two B. divergens-like samples (Est622 and Est746) were amplified from I. persulcatus ticks and generated 350-bp amplicons of the partial 18S rRNA gene. They were identical to sequences previously detected in roe deer and reported as B. divergens in Slovenia (GenBank AY572456), Poland (GenBank DQ083544), and Spain (GenBank DQ866844), whereas identical sequences were classified as Babesia capreoli in France (GenBank AY726009, FJ944827, FJ944828). Therefore, the distinction between the two closely related Babesia species, B. divergens and B. capreoli, remains questionable. We reported our Estonian sequences as B. divergens-like, although the Estonian samples had G at nucleotide position 631 and T at nucleotide position 663 of the 18S rRNA gene as that was proposed as a feature of B. capreoli (Malandrin et al. 2010). Other B. divergens and B. divergens-like sequences from Europe, United States, and West Siberia showed 98.2%–99.7% of identity with the Estonian samples amplified in the present study (Fig. 2).
The 6 sequenced samples (Est788, Est670, Est916, Est1148, Est1362, and Est1444) of the 15 ones found to be positive by RLB only with the universal Babesia spp. probe were identified as EU1 after sequencing. All six were amplified from I. ricinus ticks and produced 350-bp amplicons that were identical to the Babesia sp. EU1 sequences detected from I. ricinus in France (GenBank FJ215873) and Slovenia (GenBank AY553915), from roe deer in Slovenia (GenBank AY572457) and France (GenBank EF185818), from human blood in Italy (GenBank AY046575), and from I. persulcatus in West Siberia (GenBank GU734773) (Fig. 2). Babesia sp. EU1 was found only in I. ricinus even in an area (Laeva) where the proportion of I. ricinus ticks is only 20%.
Discussion
The present study revealed for the first time the presence of Babesia in Estonia. Our data showed that the potentially pathogenic species B. microti, Babesia sp. EU1, and B. divergens-like circulated in I. ricinus and I. persulcatus ticks in different areas in Estonia, with a total prevalence rate of 1.4%. A similar prevalence in ticks has been reported from South Germany (1%) (Hartelt et al. 2004) and Switzerland (0.7%–1.7%) (Casati et al. 2006). However, much higher Babesia spp. prevalence rates were reported in I. ricinus ticks from Slovenia (9.6%) (Duh et al. 2001), France (6.1%–20.6%) (Halos et al. 2005, Cotté et al. 2010), and Austria (51.8%) (Blaschitz et al. 2008). The distribution of infected ticks is mosaic and varies during seasons and years; thus, a comparison of tick-borne pathogen prevalence rates between countries should be performed with caution.
B. microti was the most frequently found Babesia species in Estonia. We found identical B. microti sequences in I. persulcatus and I. ricinus ticks; thus, we suggest that both tick species play a role in the transmission and maintenance of B. microti in natural foci in Estonia. All detected sequences clustered together with zoonotic “US”-type B. microti strains, which were widely distributed in Europe, United States, and West Siberia. The possibility to utilize several Ixodes species as vector may be the reason for worldwide spreading of B. microti “US”-type strains.
We found B. divergens-like (probably B. capreoli) sequences only in I. persulcatus ticks, whereas in the other European countries such as Slovenia, Germany, and Switzerland, this species of Babesia was detected in I. ricinus (Duh et al. 2001, Hartelt et al. 2004, Casati et al. 2006). Moreover, the Estonian strains were identical to the other European strains in the partial 18S rRNA gene region; thus, we suggest that B. divergens could use both tick vectors for its transmission and maintenance in natural foci (Fig. 2).
In the present study, Babesia sp. EU1 was detected only in I. ricinus ticks even in areas where I. persulcatus predominated (85% of collected ticks). Recently, it was demonstrated that I. ricinus is a competent vector for Babesia sp. EU1 (Bonnet et al. 2007, 2009, Becker et al. 2009). However, Babesia sp. EU1 was found also in I. persulcatus, suggesting it as a vector in West Siberia (Rar et al. 2010). Our Estonian sequences were identical to the European as well as Siberian ones in the partial 18S rRNA gene region (Fig. 2). Thus, it needs to be clarified whether Babesia sp. EU1 is not able to utilize I. persulcatus as a vector in Estonia or the detection of this Babesia species only in I. ricinus is due to a collection bias.
A close relationship of the Estonian and other Babesia sequences was confirmed by phylogenetic analysis. On the phylogenetic tree based on the partial 18S rRNA gene, the Estonian sequences clustered together with other B. microti, B. divergens/B. divergens-like, and Babesia sp. EU1 sequences from Europe, United States, and West Siberia with a high bootstrap support (Fig. 2). Moreover, the analyzed sequences of B. microti and Babesia sp. EU1 were identical in the 18S partial gene region to sequences reported in ill humans, although until now there have been no reports of human infection due to Babesia spp. in Estonia.
The results of the present study demonstrated for the first time the presence of B. microti, B. divergens-like, and Babesia sp. EU1 in natural populations of Ixodes ticks in Estonia, which should be considered as a possible risk of transmission to humans.
Footnotes
Acknowledgments
The authors are grateful to Tatjana Avsic-Zupanc for providing DNA of B. divergens and B. microti. This work was supported by the Estonian Science Foundation (Grant ETF 6938), VISBY project 01347/2007, and also the EU Grant Goce-2003-010284 EDEN; it is cataloged by the EDEN Steering Committee as EDEN0223.
Disclaimer
The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission.
Disclosure Statement
No competing financial interests exist.
